{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-025072","form_type":"8-K","ticker":"ABT","cik":"0000001800","company_name":"ABBOTT LABORATORIES","filed_at":"2022-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.279795+00:00","generated_at":"2026-06-27T06:40:50.762233+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Abbott recalls Similac infant formula from Sturgis MI plant; reaffirms EPS guidance","bullets":["Proactive voluntary recall of Similac powder infant formulas from Sturgis, MI facility; primarily US and Canada.","FY2022 adjusted diluted EPS guidance reaffirmed at at least $4.70.","Q1 2022 will include one-time specified item for recall expenses (inventory destruction, etc.); amount not yet quantified.","Company states recall expenses are not expected to have a material impact on consolidated financial statements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-025072","json":"https://secwatch.observer/filing/0001104659-22-025072.json","markdown":"https://secwatch.observer/filing/0001104659-22-025072.md","text":"https://secwatch.observer/filing/0001104659-22-025072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800/000110465922025072/0001104659-22-025072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800/000110465922025072/tm227088d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:40:50.762233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}